NCL Responds to FDA Action on Fluoride Supplements: Access Still in Question
Media Contact: Lisa McDonald, Vice President of Communications, 202-207-2829
Washington, DC – Last week, the Food and Drug Administration (FDA) announced actions to restrict the sale of unapproved ingestible fluoride prescription drug products for children. The agency has notified four companies of its intent to take enforcement action against those marketing unapproved fluoride-containing drugs labeled for use in children under age three or for older children at low or moderate risk for tooth decay.
“Fluoride remains one of the most effective and affordable tools we have to protect children’s teeth,” said NCL CEO Sally Greenberg. “While we are relieved that this is not a ban on fluoride supplements, the FDA’s actions highlight an ongoing concern about access to safe and effective fluoride sources for children. Millions of families, especially those without access to fluoridated water, depend on fluoride supplements prescribed by their healthcare providers to prevent painful and costly cavities. There is scant evidence that fluoride supplements harm children, as the FDA alleges. I myself took them when I was pregnant, and he took them as an infant, and millions of other children enjoy great dental health with no neurological effects.”
“Preventing cavities is always better than treating them. Without prevention, families face unaffordable dental bills, and children face serious long-term health consequences,” Greenberg concluded. “It is imperative not to deprive children without access to fluoridated water of other safe sources of fluoride.”
###
About the National Consumers League (NCL)
The National Consumers League, founded in 1899, is America’s pioneer consumer organization. Our mission is to protect and promote social and economic justice for consumers and workers in the United States and abroad. For more information, visit www.nclnet.org.
